Key result
Leadless pacemakers eliminate lead-related complications and are expected to reduce device infections and tricuspid regurgitation.
Why the study?
Leadless pacemakers eliminate lead-related complications and are expected to reduce device infection and tricuspid regurgitation, but their feasibility in patients with left ventricular assist devices is unclear.
Helix-fixation leadless pacemakers may offer a feasible pacing strategy in patients with left ventricular assist devices by eliminating lead-related complications.
May offer leadless pacing option in LVAD patients; leaves open need for prospective validation on infection and TR reduction.
A leadless pacemaker (LP) is an intracardiac cardiac implantable electronic device (CIED) that is implanted directly into the cardiac chamber without a subcutaneous chest pocket or transvenous leads.1 Therefore, lead-related complications are eliminated, and LPs are expected to reduce the risk of device infection and tricuspid regurgitation (TR).2,3
No takes yet. Share an insight, caveat, or question.
Yakabe et al. (2026) studied this question. Leadless pacemakers eliminate lead-related complications and are expected to reduce the risk of device infection and tricuspid regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: